What Are IBWF's Main Research Competencies in Bioactive Compounds and Microbiology?

IBWF (the Institute of Biotechnology and Drug Research) concentrates on finding and developing new biologically active substances and enzymes from fungi. Its core competencies span the full path from isolating active compounds out of fungal material to explaining how those compounds work at the molecular level and how the producing organism builds them. This makes the institute relevant if you are looking for natural-product lead structures for pharmaceutical or agricultural applications, or for partners with long-standing experience in fungal strain work and test-system development.

Discovery and characterization of bioactive compounds

The institute's stated driving force is the identification, isolation, and purification of biologically active compounds in order to find new lead structures for pharmaceutical and agricultural applications. This work is supported by a broad set of different screening systems that IBWF developed and established over time.

In practice, this competency covers:

• Identification of biologically active compounds from fungal material
• Isolation and purification of those compounds
• Screening against a range of test systems to detect biological activity
• Lead-structure discovery aimed at pharmaceutical and agricultural use

The institute describes its accumulated expertise as a wide range of knowledge in natural-product research and test-system development, built on long-term experience in these fields.

Molecular targets and biosynthesis

Beyond finding active substances, IBWF works on understanding why they are active and how they are made. Its stated fields of competence include:

• Identification and characterization of molecular targets of active compounds
• Biosynthesis of specific substances
• Elucidation of regulation mechanisms of biosynthetic pathways

This is the mechanistic layer of the institute's work: determining what an active compound binds or inhibits, and tracing the biochemical route by which a fungus produces it.

A worked example: the strobilurins

The most cited commercial outcome of this approach is the strobilurin fungicides. In 1977, Anke and Steglich described strobilurin A, a strongly antifungal antibiotic, from liquid cultures of Strobilurus tenacellus, a basidiomycete growing on pine cones. In 1981, the molecular target of the strobilurins was elucidated: their activity was found to be based on inhibition of fungal respiration. First synthetic derivatives followed in 1986 through cooperation. Strobilurin fungicides are now in worldwide use as agricultural fungicides, marketed by BASF and others.

This sequence — isolate a natural product, identify its target, then derive synthetic variants — illustrates how the institute's competencies connect discovery to application.

Microbial enzymes and industrial applications

IBWF's experience also extends to microbial enzymes, with stated knowledge relevant to:

• Biotransformation
• Bioremediation
• Other industrial purposes

This is a separate competency track from the pharmaceutical and agricultural lead-structure work, aimed at enzyme-based processes rather than bioactive small molecules.

Fungal strain collection and extracts as a research base

The competencies above rest on a large non-profit fungal strain collection of high diversity. It includes ascomycetes, basidiomycetes, zygomycetes, and imperfect fungi, as well as coprophiles and endophytes. Fungal extracts from each strain, and a number of enzymes derived from them, are available for initial investigations into biological activity.

This collection is what makes collaboration feasible: partners can access strains, extracts, and enzymes as starting material for joint work.

Track record and collaboration

IBWF was founded in 1998 as a non-profit research institute by professors T. and H. Anke, bringing together microbiologists, biochemists, and chemists. Its work is documented in over 400 publications and 20 patents concerning fungal natural products and microbial research. The institute states that this record confirms its leading international position.

For partners in industry and academia, the institute explicitly frames its strain collection and metabolites as opportunities for collaboration projects in pharmaceutical and agricultural applications.

How to judge whether IBWF fits your need

The clearest fit is when your interest lies in fungal natural products — whether you want compounds found and characterized, mechanisms explained, or strains and extracts to work with. If your need falls outside fungal bioactive compounds and microbial enzymes, the institute's stated competencies do not cover it.